Selective internal radiation therapy segmentectomy: A new minimally invasive curative option for primary liver malignancies?
- PMID: 38764771
- PMCID: PMC11099395
- DOI: 10.3748/wjg.v30.i18.2379
Selective internal radiation therapy segmentectomy: A new minimally invasive curative option for primary liver malignancies?
Abstract
Transarterial radioembolization or selective internal radiation therapy (SIRT) has emerged as a minimally invasive approach for the treatment of tumors. This percutaneous technique involves the local, intra-arterial delivery of radioactive microspheres directly into the tumor. Historically employed as a palliative measure for liver malignancies, SIRT has gained traction over the past decade as a potential curative option, mirroring the increasing role of radiation segmentectomy. The latest update of the BCLC hepatocellular carcinoma guidelines recognizes SIRT as an effective treatment modality comparable to other local ablative methods, particularly well-suited for patients where surgical resection or ablation is not feasible. Radiation segmentectomy is a more selective approach, aiming to deliver high-dose radiation to one to three specific hepatic segments, while minimizing damage to surrounding healthy tissue. Future research efforts in radiation segmentectomy should prioritize optimizing radiation dosimetry and refining the technique for super-selective administration of radiospheres within the designated hepatic segments.
Keywords: Hepatocellular carcinoma; Personalised dosimetry; Primary liver malignancies; Radiation segmentectomy; Selective internal radiation therapy; Transarterial radioembolization.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures
Similar articles
-
Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.Tech Vasc Interv Radiol. 2019 Jun;22(2):49-57. doi: 10.1053/j.tvir.2019.02.003. Epub 2019 Feb 27. Tech Vasc Interv Radiol. 2019. PMID: 31079710 Review.
-
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes.J Gastrointest Cancer. 2020 Mar;51(1):152-158. doi: 10.1007/s12029-019-00221-0. J Gastrointest Cancer. 2020. PMID: 30911980 Free PMC article.
-
[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].Rofo. 2010 Aug;182(8):660-70. doi: 10.1055/s-0029-1245380. Epub 2010 Apr 19. Rofo. 2010. PMID: 20405369 Review. German.
-
Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection.Cardiovasc Intervent Radiol. 2018 May;41(5):816-820. doi: 10.1007/s00270-018-1903-6. Epub 2018 Feb 21. Cardiovasc Intervent Radiol. 2018. PMID: 29468286 Free PMC article.
-
Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.Int J Hyperthermia. 2022;39(1):620-626. doi: 10.1080/02656736.2021.1933215. Int J Hyperthermia. 2022. PMID: 35465813 Review.
References
-
- Simon N, Warner RR, Baron MG, Rudavsky AZ. Intra-arterial irradiation of carcinoid tumors of the liver. Am J Roentgenol Radium Ther Nucl Med. 1968;102:552–561. - PubMed
-
- Mantravadi RV, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology. 1982;142:783–786. - PubMed
-
- Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum. 1979;22:371–375. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous